SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3ASR

S-3ASR

Registration Statements
View HTML
S-4

Registration of securities issued in business combination transactions

Registration Statements
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
S-4

Registration of securities issued in business combination transactions

Registration Statements
View HTML
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe